SC2006guidelinesforthemanagementofpatientswithatrialfibrillation--executivesummary:areportoftheAmericanCollegeofCardiology/mitteeforPracticeGuidelines(mitteetoRevisethe2001GuidelinesfortheManagementofPatientsWithAtrialFibrillation)[J].JAmCoilCardiol,2006,48(4):854-906.[2]SteinPD,AIpertjs,BusseyHI,eta1.Antithrombotictherapyinpatientswithmechanicalandbiologicalprostheticheartvalves[J].Chest,2001,119(1Suppl):220F'-227S.[3]胡大一,马长生.心脏病学实践2007—新进展与临床案例[M].北京:人民卫生出版社,2007.459-461,674-678.[4]夏宏器,邓开伯.实用心律失常学[M].第2版.北京:中国协和医科大学出版社,2008.301-361.[5]中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-152.[6]付研,王旭东.2003年美国心脏协会/美国心脏病学会华法林治疗指南概要(3)[J].中国医药导刊,2004,6(1):63-67.[7]朱剑萍,赵蕊.华法林药效的影响因素[J].临床药物治疗杂志,2009,7(3):55-58.[8]钟伟,周舍典,彭俊等.影响华法林疗效诸因素的综合分析[J].中国现代药物应用,2010,4(6):29-31.